AbelZeta Pharma is a global cell therapy leader focused on discovering, developing and manufacturing therapeutics to address unmet medical needs across hematologic malignancies, inflammatory and immunological diseases and solid tumors.Partners: AstraZeneca, Janssen (J&J), NovartisInvestors: HSG, Yunfeng Capital, GIC, TF Capital, CICC Capital, Sailing Capital, Dangdai Group, AstraZeneca-CICC Fund170,000+ different files670+ separate archives with experiments on various candidates All studies: CAR032, CAR39, CAR66, CAR168, TIL, CD, Tcell, etc. There are a huge number of files and studies, all of which are confidential and valuable for competitive research. https://www.abelzeta.com/